• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The first generation ABSORB BVS scaffold; to be or not to be?

作者信息

Henriques J P S, Elias J

机构信息

Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Neth Heart J. 2017 Jul;25(7-8):416-418. doi: 10.1007/s12471-017-1007-y.

DOI:10.1007/s12471-017-1007-y
PMID:28643296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5513991/
Abstract
摘要

相似文献

1
The first generation ABSORB BVS scaffold; to be or not to be?
Neth Heart J. 2017 Jul;25(7-8):416-418. doi: 10.1007/s12471-017-1007-y.
2
Scaffold underexpansion and late lumen loss after bioresorbable scaffold implantation: Insights from ABSORB JAPAN trial.生物可吸收支架植入后支架扩张不足和晚期管腔丢失：来自ABSORB日本试验的见解。
Int J Cardiol Heart Vasc. 2020 Sep 4;31:100623. doi: 10.1016/j.ijcha.2020.100623. eCollection 2020 Dec.
3
Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent.比较生物可吸收依维莫司洗脱冠状动脉支架（修订版 1.0 和 1.1）与金属依维莫司洗脱支架的体内急性支架回缩。
Catheter Cardiovasc Interv. 2011 Jul 1;78(1):3-12. doi: 10.1002/ccd.22864. Epub 2011 Mar 16.
4
Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation: Analysis From the ABSORB Trials.生物可吸收血管支架置入术后技术对结局的影响：ABSORB 试验分析。
J Am Coll Cardiol. 2017 Dec 12;70(23):2863-2874. doi: 10.1016/j.jacc.2017.09.1106. Epub 2017 Oct 31.
5
Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial.生物可吸收血管支架与依维莫司洗脱支架经皮冠状动脉介入治疗后的急性获益和晚期管腔丢失比较：随机试验前的探索性观察研究。
EuroIntervention. 2014 Oct;10(6):672-80. doi: 10.4244/EIJV10I6A118.
6
Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry.使用生物可吸收血管支架的 5 年临床结果：来自 FRANCE ABSORB 注册研究的结果。
Arch Cardiovasc Dis. 2022 Oct;115(10):505-513. doi: 10.1016/j.acvd.2022.05.008. Epub 2022 Sep 5.
7
Overview of the 2016 U.S. Food and Drug Administration Circulatory System Devices Advisory Panel Meeting on the Absorb Bioresorbable Vascular Scaffold System.2016 年美国食品和药物管理局循环系统设备顾问小组会议概述：Absorb 生物可吸收血管支架系统。
JACC Cardiovasc Interv. 2016 Sep 12;9(17):1757-64. doi: 10.1016/j.jcin.2016.06.027.
8
Three to four years outcomes of the absorb bioresorbable vascular scaffold versus second-generation drug-eluting stent: A meta-analysis.吸收性生物可吸收血管支架与第二代药物洗脱支架的三至四年结果：荟萃分析。
Catheter Cardiovasc Interv. 2020 Feb;95(2):216-223. doi: 10.1002/ccd.28290. Epub 2019 Apr 19.
9
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial.完全降解依维莫司洗脱生物可吸收支架吸收前后的临床结果：ABSORB III 试验 5 年随访。
Circulation. 2019 Dec 3;140(23):1895-1903. doi: 10.1161/CIRCULATIONAHA.119.042584. Epub 2019 Sep 25.
10
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.生物可吸收血管支架治疗可诱导新生内膜帽的形成，该内膜帽可封闭下方斑块，同时不影响管腔尺寸：这一概念基于系列光学相干断层扫描数据。
EuroIntervention. 2015 Nov;11(7):746-56. doi: 10.4244/EIJY14M10_06.

引用本文的文献

1
Drug-eluting, balloon-expandable, bioresorbable vascular scaffolds reduce neointimal thickness and stenosis in an animal model of percutaneous peripheral intervention.药物洗脱、球囊扩张、可生物吸收的血管支架可减少经皮外周介入动物模型中的新生内膜厚度和狭窄。
JVS Vasc Sci. 2023 Jun 8;4:100114. doi: 10.1016/j.jvssci.2023.100114. eCollection 2023.
2
A Novel PLLA/MgF Coating on Mg Alloy by Ultrasonic Atomization Spraying for Controlling Degradation and Improving Biocompatibility.一种通过超声雾化喷涂在镁合金上制备的新型聚乳酸/氟化镁涂层，用于控制降解和提高生物相容性。
Materials (Basel). 2023 Jan 10;16(2):682. doi: 10.3390/ma16020682.
3
Long-term outcome of first 300 implanted Absorb bioresorbable vascular scaffolds in an all-comers Middle East population.在中东所有人群中首批植入的300个Absorb生物可吸收血管支架的长期结果。
J Int Med Res. 2019 Jan;47(1):173-187. doi: 10.1177/0300060518798994. Epub 2018 Sep 21.
4
Adverse events with bioresorbable vascular scaffolds in routine percutaneous coronary interventions: "coup de théâtre" or unfinished play?生物可吸收血管支架在常规经皮冠状动脉介入治疗中的不良事件：“戏剧性事件”还是未完成的剧目？
J Thorac Dis. 2017 Aug;9(8):2303-2307. doi: 10.21037/jtd.2017.07.74.

本文引用的文献

1
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.常规经皮冠状动脉介入治疗中生物可吸收支架与金属支架的对比
N Engl J Med. 2017 Nov 2;377(18):1791-2. doi: 10.1056/NEJMc1711903.
2
Recommendations for the use of bioresorbable vascular scaffolds in percutaneous coronary interventions : 2017 revision.经皮冠状动脉介入治疗中生物可吸收血管支架使用的推荐意见：2017年修订版
Neth Heart J. 2017 Jul;25(7-8):419-428. doi: 10.1007/s12471-017-1014-z.
3
Mid-term and long-term safety and efficacy of bioresorbable vascular scaffolds versus metallic everolimus-eluting stents in coronary artery disease: A weighted meta-analysis of seven randomised controlled trials including 5577 patients.生物可吸收血管支架与金属依维莫司洗脱支架治疗冠状动脉疾病的中期和长期安全性及有效性：一项纳入5577例患者的7项随机对照试验的加权荟萃分析
Neth Heart J. 2017 Jul;25(7-8):429-438. doi: 10.1007/s12471-017-1008-x.
4
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.对比依维莫司洗脱生物可吸收支架与依维莫司洗脱金属支架治疗冠状动脉狭窄的疗效（ABSORB II）：3 年随机、对照、单盲、多中心临床试验。
Lancet. 2016 Nov 19;388(10059):2479-2491. doi: 10.1016/S0140-6736(16)32050-5. Epub 2016 Oct 30.
5
Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.生物可吸收冠状动脉支架血栓形成：多中心临床特征、机制和预测因素的综合分析。
J Am Coll Cardiol. 2016 Mar 1;67(8):921-931. doi: 10.1016/j.jacc.2015.12.019.
6
Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings.极晚期支架血栓：冠状动脉内影像学及组织病理学和光谱学研究结果。
J Am Coll Cardiol. 2015 Oct 27;66(17):1901-14. doi: 10.1016/j.jacc.2015.08.853.
7
Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis.药物洗脱支架和裸金属支架的长期安全性：来自综合网络荟萃分析的证据。
J Am Coll Cardiol. 2015 Jun 16;65(23):2496-507. doi: 10.1016/j.jacc.2015.04.017.